In our digitally connected world, e-Learning is being used ever more frequently as a method of information delivery. Utilized by industries around the globe, e-Learning allows for efficient and cost-effective continued learning and training opportunities. Localizing e-Learning material enables users to access course materials easily from anywhere around the world through the internet or company intranet.
Marketing translations is a vital step across all industries. Due to the cultural differences that affect global markets, you need to take special care when presenting your branding messages. Unlike technical documents, marketing communications material is highly visible and often written in highly expressive language. If you want to reach a global audience, it is essential to make sure your marketing messages resonate cross-culturally. Transcreation makes this possible.
At this point, there is no real question as to whether or not Earth’s language diversity is dwindling, as it already clearly is. But there is a question as to how much of this phenomenon is due to increasingly powerful machine translation (MT) tools such as neural machine translation (NMT) versus how much is due to natural processes.
By taking it to the grasslands, the 13th Annual Summit will be an opportunity for everyone in the company to reconnect with the essentials of being a CSOFTer and to rediscover what it means to be part of a family and a team. So, put away your cocktail attire and pack your hiking boots, everyone, because CSOFT is going wild!
An in-country review (ICR), also referred to as an in-house review, is an essential step in life science translations. With translations for industries such as medical, pharmaceuticals, and biotechnologies, accuracy is of the utmost importance. Generally, in-country reviews will be undertaken by someone on the client’s side.
Several years ago, clinical trials in India were a booming business. After becoming fully compliant withTRIPS in 2005, India was seen as a favorable place to conduct clinical trials as they boast a huge genetically diverse population, as well as a multitude of skilled health professionals. Additionally, it is estimated that India based clinical trials offered a 35-60% cost reduction compared to western based trials.